Janux Therapeutics
JANX
#6201
Rank
A$1.53 B
Marketcap
A$25.17
Share price
-3.99%
Change (1 day)
-27.53%
Change (1 year)

Earnings for Janux Therapeutics (JANX)

Earnings in 2026 (TTM): -A$0.18 Billion

According to Janux Therapeutics's latest financial reports the company's current earnings are A$13.73 Million. In 2025 the company made an earning of -A$0.16 Billion a decrease over its 2024 earnings that were of -A$96.31 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Janux Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.18 Billion7.91%
2025 -A$0.16 Billion64.69%
2024 -A$96.31 Million18.36%
2023 -A$81.37 Million-7.56%
2022 -A$88.02 Million93.01%
2021 -A$45.61 Million381.6%
2020 -A$9.47 Million